Jacob A Kanter1, Haiying Sun2, Stephen Chiu1, Malcolm M DeCamp1, Peter H S Sporn3, Jacob I Sznajder2, Ankit Bharat4. 1. Division of Thoracic Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL. 2. Division of Pulmonary & Critical Care Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. 3. Division of Pulmonary & Critical Care Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL; Jesse Brown Veterans Affairs Medical Center, Chicago, IL. 4. Division of Thoracic Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL. Electronic address: abharat@nm.org.
Abstract
BACKGROUND: Prolonged air leak (PAL) is an important cause of morbidity and mortality after lung resection, but its pathogenesis has not been elucidated. Migration of alveolar type II epithelial cells is essential for lung wound repair. Here we determined the role of C-X-C motif chemokine 12 (CXCL12) on alveolar epithelial cell migration and lung wound healing. METHODS: CXCL12 in the pleural fluid of patients was analyzed using enzyme-linked immunosorbent assay. Human A549 and murine MLE12 alveolar epithelial cell lines were used for wound closure, cell migration, and proliferation assays. Western blot was used to analyze Rac1 and cofilin. RESULTS: Pleural CXCL12 was decreased in patients with PAL (1,389 ± 192 vs 3,270 ± 247 pg/mL; P < .0001). CXCL12 enhanced scratch wound closure in both A549 (77.9 ± 0.7% vs 71.5 ± 0.4%; P = .0016) and MLE12 (92.9 ± 4.9% vs 66.0 ± 4.8%; P = .017). CXCL12 enhanced migration by 57% in A549 (P = .0008) and by 86% in MLE12 (P < .0001). AMD3100, a selective CXCR4 antagonist, prevented the effects of CXCL12. CXCL12 increased Rac1 and cofilin activation but did not change bromodeoxyuridine incorporation or cell counts. CONCLUSION: Reduced pleural CXCL12 is associated with PAL. CXCL12 promotes alveolar epithelial cell migration by binding to its receptor CXCR4 and may have a role in lung healing. CXCL12-mediated alveolar epithelial cell migration is associated with Rac1 and cofilin activation.
BACKGROUND: Prolonged air leak (PAL) is an important cause of morbidity and mortality after lung resection, but its pathogenesis has not been elucidated. Migration of alveolar type II epithelial cells is essential for lung wound repair. Here we determined the role of C-X-C motif chemokine 12 (CXCL12) on alveolar epithelial cell migration and lung wound healing. METHODS:CXCL12 in the pleural fluid of patients was analyzed using enzyme-linked immunosorbent assay. HumanA549 and murine MLE12 alveolar epithelial cell lines were used for wound closure, cell migration, and proliferation assays. Western blot was used to analyze Rac1 and cofilin. RESULTS:PleuralCXCL12 was decreased in patients with PAL (1,389 ± 192 vs 3,270 ± 247 pg/mL; P < .0001). CXCL12 enhanced scratch wound closure in both A549 (77.9 ± 0.7% vs 71.5 ± 0.4%; P = .0016) and MLE12 (92.9 ± 4.9% vs 66.0 ± 4.8%; P = .017). CXCL12 enhanced migration by 57% in A549 (P = .0008) and by 86% in MLE12 (P < .0001). AMD3100, a selective CXCR4 antagonist, prevented the effects of CXCL12. CXCL12 increased Rac1 and cofilin activation but did not change bromodeoxyuridine incorporation or cell counts. CONCLUSION: Reduced pleuralCXCL12 is associated with PAL. CXCL12 promotes alveolar epithelial cell migration by binding to its receptor CXCR4 and may have a role in lung healing. CXCL12-mediated alveolar epithelial cell migration is associated with Rac1 and cofilin activation.
Authors: Malcolm M DeCamp; Eugene H Blackstone; Keith S Naunheim; Mark J Krasna; Douglas E Wood; Yvonne M Meli; Robert J McKenna Journal: Ann Thorac Surg Date: 2006-07 Impact factor: 4.330
Authors: Abel Gómez-Caro; Maria Jose Roca Calvo; Juan Torres Lanzas; Ryan Chau; Pedro Cascales; Pascual Parrilla Journal: Eur J Cardiothorac Surg Date: 2006-12-18 Impact factor: 4.191
Authors: Manik C Ghosh; Patrudu S Makena; Vijay Gorantla; Scott E Sinclair; Christopher M Waters Journal: Am J Physiol Lung Cell Mol Physiol Date: 2012-02-17 Impact factor: 5.464
Authors: Naizhen Wang; Khalilah L Gates; Humberto Trejo; Silvio Favoreto; Robert P Schleimer; Jacob I Sznajder; Greg J Beitel; Peter H S Sporn Journal: FASEB J Date: 2010-02-24 Impact factor: 5.191
Authors: R J Cerfolio; R P Tummala; W L Holman; G L Zorn; J K Kirklin; D C McGiffin; D C Naftel; A D Pacifico Journal: Ann Thorac Surg Date: 1998-11 Impact factor: 4.330
Authors: Ankit Bharat; Martín Angulo; Haiying Sun; Mahzad Akbarpour; Andrés Alberro; Yuan Cheng; Masahiko Shigemura; Sergejs Berdnikovs; Lynn C Welch; Jacob A Kanter; G R Scott Budinger; Emilia Lecuona; Jacob I Sznajder Journal: Am J Respir Cell Mol Biol Date: 2020-08 Impact factor: 6.914
Authors: Joel Reiter; Shelley Drummond; Ibrahim Sammour; Jian Huang; Victoria Florea; Polliana Dornas; Joshua M Hare; Claudia O Rodrigues; Karen C Young Journal: Respir Res Date: 2017-07-12
Authors: Patricia L Brazee; Pritin N Soni; Elmira Tokhtaeva; Natalia Magnani; Alex Yemelyanov; Harris R Perlman; Karen M Ridge; Jacob I Sznajder; Olga Vagin; Laura A Dada Journal: Front Immunol Date: 2017-06-01 Impact factor: 7.561